Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects.
about
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.Belimumab in the management of systemic lupus erythematosus - an update.Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program.Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus.
P2860
Q33698040-AA270D53-1443-4023-8B08-1511080C5F65Q37337375-F18CCC3F-59D2-4520-BC3C-9949BEFBDCA3Q38605480-5D922ECA-C31A-4C5F-BDF6-067AFB0834EEQ38810737-03B698DD-BE61-4649-B4CC-F5B00A7F319AQ38888137-EF1A6A6A-8007-4C23-8AD2-7F591F40AEE8Q39855585-150DA1DE-8B7F-4C59-BAE9-0A4E3E3EF4D6Q48010137-C8D31084-D3AA-4B3B-8FF8-7D2D8DB18D1F
P2860
Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@en
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@nl
type
label
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@en
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@nl
prefLabel
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@en
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
Bioavailability, Pharmacokinet ...... taneously in Healthy Subjects.
@en
P2093
Cecil Chen
David C Subich
Michele Fiscella
Wendy W Cai
William W Freimuth
Z John Zhong
P2860
P304
P356
10.1002/CPDD.54
P577
2013-08-26T00:00:00Z